$DYAI
Dyadic International Inc Stock $dyai

$dyai Overview Financials Valuation SEC Filings Company Website

2019 Q3 Form 10-Q Financial Statement

#000121380919000061 Filed on August 13, 2019

Income Statement

Concept	2019 Q3	2019 Q2	2018 Q2
Revenue	$454.5K	$390.9K	$161.3K
YoY Change	72.84%	142.35%	-23.2%
Cost Of Revenue	$384.8K	$322.2K	$129.1K
YoY Change	58.09%	149.56%	-35.44%
Gross Profit	$69.70K	$68.65K	$32.17K
YoY Change	256.47%	113.39%	221.7%
Gross Profit Margin	15.34%	17.56%	19.95%
Selling, General & Admin	$1.060M	$1.870M	$920.0K
YoY Change	3.92%	103.26%	-25.2%
% of Gross Profit	1520.72%	2724.12%	2859.81%
Research & Development	$841.3K	$818.2K	$601.2K
YoY Change	76.52%	36.1%	43.14%
% of Gross Profit	1207.02%	1191.97%	1868.82%
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$841.3K	$818.2K	$601.2K
YoY Change	76.52%	36.1%	-64.0%
Operating Profit	-$1.943M	-$2.962M	-$1.816M
YoY Change	9.11%	63.06%	9.41%
Interest Expense	$245.0K	$265.7K	$219.6K
YoY Change	1.4%	21.01%	-29.17%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$1.700M	-$2.700M	-$1.600M
YoY Change	10.39%	68.75%	18.52%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$1.698M	-$2.696M	-$1.597M
YoY Change	10.32%	68.84%	18.27%
Net Earnings / Revenue	-373.68%	-689.68%	-989.94%
Basic Earnings Per Share
Diluted Earnings Per Share	-$62.55K	-$100.6K	-$57.02K
COMMON SHARES
Basic Shares Outstanding	27.11M shares	26.76M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2019 Q3	2019 Q2	2018 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$35.46M	$36.89M	$44.33M
YoY Change	-16.6%	-16.78%	8.71%
Cash & Equivalents	$4.662M	$4.782M	$3.219M
Short-Term Investments	$30.79M	$32.10M	$41.11M
Other Short-Term Assets	$80.00K	$200.0K	$790.0K
YoY Change	-87.88%	-74.68%	-90.35%
Inventory
Prepaid Expenses
Receivables	$418.9K	$504.5K	$10.00K
Other Receivables	$500.0K	$410.0K	$460.0K
Total Short-Term Assets	$36.46M	$38.00M	$45.58M
YoY Change	-16.56%	-16.63%	-7.96%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$1.510M	$1.520M	$1.030M
YoY Change		47.57%	-76.54%
Other Assets	$50.23K	$51.58K	$160.0K
YoY Change	0.46%	-67.77%	-71.93%
Total Long-Term Assets	$2.065M	$2.069M	$1.190M
YoY Change	3341.67%	73.85%	-75.96%
TOTAL ASSETS
Total Short-Term Assets	$36.46M	$38.00M	$45.58M
Total Long-Term Assets	$2.065M	$2.069M	$1.190M
Total Assets	$38.52M	$40.07M	$46.77M
YoY Change	-11.95%	-14.33%	-14.14%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$713.4K	$963.3K	$230.0K
YoY Change	32.11%	318.81%	-28.13%
Accrued Expenses	$470.1K	$396.0K	$190.0K
YoY Change	95.88%	108.44%	-68.33%
Deferred Revenue	$93.28K	$90.57K
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.277M	$1.450M	$470.0K
YoY Change	52.0%	208.48%	-62.1%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.277M	$1.450M	$470.0K
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$1.280M	$1.450M	$470.0K
YoY Change	52.38%	208.51%	-62.1%
SHAREHOLDERS EQUITY
Retained Earnings	-$39.61M	-$37.91M
YoY Change
Common Stock	$39.47K	$39.37K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)	$18.90M	$18.93M
YoY Change
Treasury Stock Shares
Shareholders Equity	$37.24M	$38.62M	$46.30M
YoY Change
Total Liabilities & Shareholders Equity	$38.52M	$40.07M	$46.77M
YoY Change	-11.95%	-14.33%	-14.14%

Cashflow Statement

Concept	2019 Q3	2019 Q2	2018 Q2
OPERATING ACTIVITIES
Net Income	-$1.698M	-$2.696M	-$1.597M
YoY Change	10.32%	68.84%	18.27%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$1.540M	-$1.430M	-$1.720M
YoY Change	92.5%	-16.86%	-218.62%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$1.270M	$2.090M	$310.0K
YoY Change	3.25%	574.19%	-106.18%
Cash From Investing Activities	$1.270M	$2.090M	$310.0K
YoY Change	3.25%	574.19%	-106.18%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	180.0K	150.0K	0.000
YoY Change	-109.33%		-100.0%
NET CHANGE
Cash From Operating Activities	-1.540M	-1.430M	-1.720M
Cash From Investing Activities	1.270M	2.090M	310.0K
Cash From Financing Activities	180.0K	150.0K	0.000
Net Change In Cash	-90.00K	810.0K	-1.410M
YoY Change	-94.0%	-157.45%	-60.39%
FREE CASH FLOW
Cash From Operating Activities	-$1.540M	-$1.430M	-$1.720M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
	dei	Document Period End Date DocumentPeriodEndDate	2019-06-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001213809
CY2019Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	27111157	shares
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	DYADIC INTERNATIONAL INC
	dei	Entity Shell Company EntityShellCompany	false
	dei	Entity Small Business EntitySmallBusiness	true
CY2018Q4	dyai	Accrued Researchand Developmentin Process Current AccruedResearchandDevelopmentinProcessCurrent	49666	USD
CY2019Q2	dyai	Accrued Researchand Developmentin Process Current AccruedResearchandDevelopmentinProcessCurrent	90085	USD
CY2017Q2	dyai	Collaborative Arrangement Duration Of Agreement CollaborativeArrangementDurationOfAgreement	P2Y
CY2017Q2	dyai	Collaborative Arrangement Paymentfor Researchand Development Agreement CollaborativeArrangementPaymentforResearchandDevelopmentAgreement	1100000	USD
CY2017Q2	dyai	Collaborative Arrangement Paymentfor Researchand Development Agreement CollaborativeArrangementPaymentforResearchandDevelopmentAgreement	1000000	EUR
CY2018Q4	dyai	Deferred Tax Assets Valuation Allowance Coverage Percent DeferredTaxAssetsValuationAllowanceCoveragePercent	1
CY2019Q2	dyai	Deferred Tax Assets Valuation Allowance Coverage Percent DeferredTaxAssetsValuationAllowanceCoveragePercent	1
	dyai	Increase Decreasein Prepaid Researchand Development IncreaseDecreaseinPrepaidResearchandDevelopment	-448785	USD
	dyai	Increase Decreasein Prepaid Researchand Development IncreaseDecreaseinPrepaidResearchandDevelopment	-154522	USD
CY2018Q4	dyai	Investmentsand Cash Amortized Cost InvestmentsandCashAmortizedCost	41202755	USD
CY2019Q2	dyai	Investmentsand Cash Amortized Cost InvestmentsandCashAmortizedCost	38402338	USD
CY2018Q4	dyai	Prepaid Researchand Development PrepaidResearchandDevelopment	300000	USD
CY2019Q2	dyai	Prepaid Researchand Development PrepaidResearchandDevelopment	100000	USD
CY2018Q4	dyai	Prepaid Researchand Developmentin Process Current PrepaidResearchandDevelopmentinProcessCurrent	253446	USD
CY2019Q2	dyai	Prepaid Researchand Developmentin Process Current PrepaidResearchandDevelopmentinProcessCurrent	98924	USD
CY2018Q2	dyai	Research And Development Expense Contracted Services Related Party ResearchAndDevelopmentExpenseContractedServicesRelatedParty	340849	USD
	dyai	Research And Development Expense Contracted Services Related Party ResearchAndDevelopmentExpenseContractedServicesRelatedParty	733398	USD
CY2019Q2	dyai	Research And Development Expense Contracted Services Related Party ResearchAndDevelopmentExpenseContractedServicesRelatedParty	336310	USD
	dyai	Research And Development Expense Contracted Services Related Party ResearchAndDevelopmentExpenseContractedServicesRelatedParty	725783	USD
CY2018Q2	dyai	Research And Development Expense Facilities Overheadand Other ResearchAndDevelopmentExpenseFacilitiesOverheadandOther	24306	USD
	dyai	Research And Development Expense Facilities Overheadand Other ResearchAndDevelopmentExpenseFacilitiesOverheadandOther	36643	USD
CY2019Q2	dyai	Research And Development Expense Facilities Overheadand Other ResearchAndDevelopmentExpenseFacilitiesOverheadandOther	37451	USD
	dyai	Research And Development Expense Facilities Overheadand Other ResearchAndDevelopmentExpenseFacilitiesOverheadandOther	49572	USD
CY2018Q2	dyai	Research And Development Expense Including Related Party ResearchAndDevelopmentExpenseIncludingRelatedParty	942048	USD
	dyai	Sharebased Compensation Arrangementby Sharebased Payment Award Options Exercisesin Period Common Stock Issued SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisesinPeriodCommonStockIssued	397671	shares
	dyai	Sharebased Compensation Arrangementby Sharebased Payment Award Options Exercisesin Period Forfeited SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisesinPeriodForfeited	135829	shares
	dyai	Research And Development Expense Including Related Party ResearchAndDevelopmentExpenseIncludingRelatedParty	1911481	USD
CY2019Q2	dyai	Research And Development Expense Including Related Party ResearchAndDevelopmentExpenseIncludingRelatedParty	1154550	USD
	dyai	Sharebased Compensation Arrangementby Sharebased Payment Award Options Exercisesin Period Net SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisesinPeriodNet	440000	shares
	dyai	Sharebased Compensation Arrangementsby Sharebased Payment Award Options Exercisesin Period Weighted Average Market Price SharebasedCompensationArrangementsbySharebasedPaymentAwardOptionsExercisesinPeriodWeightedAverageMarketPrice	5.03
	dyai	Sharebased Compensation Arrangementby Sharebased Payment Award Options Exercisesin Period Common Stock Issued SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisesinPeriodCommonStockIssued	0	shares
	dyai	Research And Development Expense Including Related Party ResearchAndDevelopmentExpenseIncludingRelatedParty	2236393	USD
CY2018Q2	dyai	Research And Development Expense Outside Contracted Services ResearchAndDevelopmentExpenseOutsideContractedServices	481335	USD
	dyai	Research And Development Expense Outside Contracted Services ResearchAndDevelopmentExpenseOutsideContractedServices	950892	USD
CY2019Q2	dyai	Research And Development Expense Outside Contracted Services ResearchAndDevelopmentExpenseOutsideContractedServices	658499	USD
	dyai	Research And Development Expense Outside Contracted Services ResearchAndDevelopmentExpenseOutsideContractedServices	1243986	USD
CY2018Q2	dyai	Research And Development Expense Personnel Related Costs ResearchAndDevelopmentExpensePersonnelRelatedCosts	95558	USD
	dyai	Research And Development Expense Personnel Related Costs ResearchAndDevelopmentExpensePersonnelRelatedCosts	190548	USD
CY2019Q2	dyai	Research And Development Expense Personnel Related Costs ResearchAndDevelopmentExpensePersonnelRelatedCosts	122290	USD
	dyai	Research And Development Expense Personnel Related Costs ResearchAndDevelopmentExpensePersonnelRelatedCosts	217052	USD
CY2018Q4	dyai	Research And Development In Process Current ResearchAndDevelopmentInProcessCurrent	240064	USD
CY2019Q2	dyai	Research And Development In Process Current ResearchAndDevelopmentInProcessCurrent	753629	USD
CY2018Q2	dyai	Researchand Development Expense Related Party ResearchandDevelopmentExpenseRelatedParty	300000	USD
CY2018Q2	dyai	Researchand Development Expense Related Party ResearchandDevelopmentExpenseRelatedParty	340849	USD
	dyai	Researchand Development Expense Related Party ResearchandDevelopmentExpenseRelatedParty	700000	USD
	dyai	Researchand Development Expense Related Party ResearchandDevelopmentExpenseRelatedParty	733398	USD
CY2019Q2	dyai	Researchand Development Expense Related Party ResearchandDevelopmentExpenseRelatedParty	336310	USD
CY2019Q2	dyai	Researchand Development Expense Related Party ResearchandDevelopmentExpenseRelatedParty	300000	USD
	dyai	Researchand Development Expense Related Party ResearchandDevelopmentExpenseRelatedParty	725783	USD
	dyai	Researchand Development Expense Related Party ResearchandDevelopmentExpenseRelatedParty	700000	USD
CY2019Q2	dyai	Sharebased Compensation Arrangementby Sharebased Payment Award Numberof Boardof Directors SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofBoardofDirectors	3	board_of_director
	dyai	Sharebased Compensation Arrangementby Sharebased Payment Award Options Exercisesin Period Cash SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisesinPeriodCash	93500	shares
	dyai	Sharebased Compensation Arrangementby Sharebased Payment Award Options Exercisesin Period Common Stock SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisesinPeriodCommonStock	304171	shares
CY2017Q4	dyai	Tax Cutsand Jobs Act Change In Alternative Minimum Tax Income Tax Benefit TaxCutsandJobsActChangeInAlternativeMinimumTaxIncomeTaxBenefit	1001233	USD
CY2018Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	309060	USD
CY2019Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	963264	USD
CY2018Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	68996	USD
CY2019Q2	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	127617	USD
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	318744	USD
CY2019Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	504510	USD
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	399576	USD
CY2019Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	396041	USD
CY2018Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	0	USD
CY2019Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	82018	USD
CY2018Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	94385230	USD
CY2019Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	95424178	USD
CY2018Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	269596	USD
CY2018Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	73425	USD
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	309563	USD
CY2019Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	580603	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	890166	USD
CY2018Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	73425	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	343021	USD
CY2019Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	580603	USD
CY2019Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4108390	shares
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	890166	USD
CY2018Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	USD
CY2019Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	189246	USD
CY2018Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4108390	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3441890	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3441890	shares
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-1989	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-10966	USD
CY2018Q4	us-gaap	Assets Assets	43300807	USD
CY2019Q2	us-gaap	Assets Assets	40069342	USD
CY2018Q4	us-gaap	Assets Current AssetsCurrent	42748052	USD
CY2019Q2	us-gaap	Assets Current AssetsCurrent	38000481	USD
CY2018Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	USD
CY2019Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	26111	USD
CY2018Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	85321	USD
CY2019Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	4775	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2386314	USD
CY2019Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4781520	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	2386314	USD
CY2019Q2	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	4781520	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5786348	USD
CY2018Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3218820	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2386314	USD
CY2019Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4781520	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2567528	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2395206	USD
CY2018Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2019Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2019Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	38966988	shares
CY2019Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	39364659	shares
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	26713486	shares
CY2019Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	27111157	shares
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	38967	USD
CY2019Q2	us-gaap	Common Stock Value CommonStockValue	39365	USD
CY2018Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	141002	USD
CY2019Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	90572	USD
CY2018Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	129116	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	275925	USD
CY2019Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	322228	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	650131	USD
CY2018Q2	us-gaap	Costs And Expenses CostsAndExpenses	1977508	USD
	us-gaap	Costs And Expenses CostsAndExpenses	4391587	USD
CY2019Q2	us-gaap	Costs And Expenses CostsAndExpenses	3352388	USD
	us-gaap	Costs And Expenses CostsAndExpenses	6196235	USD
CY2018Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	4600000	USD
CY2019Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	5700000	USD
CY2018Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.06
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.13
CY2019Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.10
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-102000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	0	USD
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-30360	USD
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	105002	USD
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-17846	USD
CY2018Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	268287	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	44491	USD
CY2019Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	258616	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	10358	USD
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.18
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-265121	USD
CY2018Q2	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	15198	USD
	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	10358	USD
CY2019Q2	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-4932	USD
	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-10966	USD
CY2018Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	921542	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2214539	USD
CY2019Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1870678	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3298745	USD
CY2018Q4	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	38816441	USD
CY2019Q2	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	32104149	USD
CY2018Q4	us-gaap	Held To Maturity Securities Noncurrent HeldToMaturitySecuritiesNoncurrent	0	USD
CY2019Q2	us-gaap	Held To Maturity Securities Noncurrent HeldToMaturitySecuritiesNoncurrent	1516670	USD
CY2018Q2	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-1596637	USD
	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-3639929	USD
CY2019Q2	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-2695792	USD
	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-4870150	USD
CY2018Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2019Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	900	USD
CY2018Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	506866	USD
CY2019Q2	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	0	USD
CY2018Q4	us-gaap	Income Taxes Receivable Noncurrent IncomeTaxesReceivableNoncurrent	500616	USD
CY2019Q2	us-gaap	Income Taxes Receivable Noncurrent IncomeTaxesReceivableNoncurrent	500616	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-275745	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	665126	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-3535	USD
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	41815	USD
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-50430	USD
	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	0	USD
	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-506866	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	14973	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-59867	USD
CY2018Q2	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	219585	USD
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	406042	USD
CY2019Q2	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	265722	USD
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	532684	USD
CY2018Q4	us-gaap	Interest Receivable Current InterestReceivableCurrent	294240	USD
CY2019Q2	us-gaap	Interest Receivable Current InterestReceivableCurrent	399242	USD
	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	492398	USD
	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	90785	USD
	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	23571163	USD
CY2018Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2019Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2018Q4	us-gaap	Investments And Cash InvestmentsAndCash	41117434	USD
CY2019Q2	us-gaap	Investments And Cash InvestmentsAndCash	38423674	USD
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	43300807	USD
CY2019Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	40069342	USD
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	849638	USD
CY2019Q2	us-gaap	Liabilities Current LiabilitiesCurrent	1449877	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-374820	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	149180	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	186295	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	5104837	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2377014	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2840965	USD
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	-2043292	USD
CY2018Q2	us-gaap	Net Income Loss NetIncomeLoss	-1596637	USD
	us-gaap	Net Income Loss NetIncomeLoss	-3639929	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-2175258	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	-2695792	USD
	us-gaap	Net Income Loss NetIncomeLoss	-4871050	USD
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2018Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1816222	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-4045971	USD
CY2019Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2961514	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-5402834	USD
CY2018Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	81623	USD
CY2019Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	47340	USD
CY2018Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	52139	USD
CY2019Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	51575	USD
CY2018Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	91725	USD
CY2019Q2	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	103030	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	374820	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	30320705	USD
CY2018Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2019Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2018Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2019Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2018Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2019Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2018Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2019Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2018Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	172001	USD
CY2019Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	112136	USD
CY2018Q4	us-gaap	Prepaid Insurance PrepaidInsurance	77249	USD
CY2019Q2	us-gaap	Prepaid Insurance PrepaidInsurance	8214	USD
CY2018Q4	us-gaap	Prepaid Taxes PrepaidTaxes	3027	USD
CY2019Q2	us-gaap	Prepaid Taxes PrepaidTaxes	892	USD
CY2019Q2	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	500000	USD
	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	102000	USD
	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	506866	USD
	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	30507000	USD
	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	28676000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	149180	USD
CY2018Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	601199	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1178083	USD
CY2019Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	818240	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1510610	USD
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-33043113	USD
CY2019Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-37914163	USD
CY2018Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	161286	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	345616	USD
CY2019Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	390874	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	793401	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	343021	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	890166	USD
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2848573	shares
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1.65
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	0	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1089000	shares
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1149461	USD
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	18532876	USD
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3552890	shares
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4108390	shares
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.57
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.75
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.59
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0.00
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.00
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.26
CY2019Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	13139047	USD
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y9M14D
CY2018	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y0M22D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y0M15D
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	533500	shares
CY2018Q1	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	374820	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	149180	USD
CY2016Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	15000000	USD
CY2017Q3	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	5000000	USD
CY2016Q1	us-gaap	Stock Repurchase Program Period In Force1 StockRepurchaseProgramPeriodInForce1	P1Y
CY2017Q3	us-gaap	Stock Repurchase Program Period In Force1 StockRepurchaseProgramPeriodInForce1	P1Y
CY2017Q4	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	4462339	USD
CY2016Q1	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	15000000	USD
CY2017Q1	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	2551717	USD
CY2017Q3	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	5000000	USD
CY2018Q3	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	2158297	USD
CY2019Q2	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	149180	USD
CY2018Q1	us-gaap	Stockholders Equity StockholdersEquity	47826748	USD
CY2018Q2	us-gaap	Stockholders Equity StockholdersEquity	46303536	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	42451169	USD
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	40585474	USD
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	38619465	USD
CY2018Q1	us-gaap	Stockholders Equity StockholdersEquity	49975264	USD
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	42451169	USD
CY2016Q1	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	1.35
CY2017Q1	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	1.54
CY2017Q1	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	1.58
	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	1.41
	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	1.40
	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	1.52
CY2018Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	12253502	shares
CY2019Q2	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	12253502	shares
CY2016Q1	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	2136752	shares
CY2017Q1	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	2363590	shares
CY2017Q1	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	7863980	shares
	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	381607	shares
	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	1644325	shares
	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	14390254	shares
CY2018Q4	us-gaap	Treasury Stock Value TreasuryStockValue	18900000	USD
CY2018Q4	us-gaap	Treasury Stock Value TreasuryStockValue	18929915	USD
CY2019Q2	us-gaap	Treasury Stock Value TreasuryStockValue	18900000	USD
CY2019Q2	us-gaap	Treasury Stock Value TreasuryStockValue	18929915	USD
CY2016Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	2884615	USD
CY2017Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	3639929	USD
CY2017Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	12448283	USD
	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	537661	USD
	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	2304042	USD
	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	21814530	USD
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2019Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2018Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	28060811	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	28109756	shares
CY2019Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	26828754	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	26771439	shares
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;padding-top:0px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Concentrations</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#000000;">The Company’s financial instruments that are potentially subject to concentrations of credit risk consist primarily of cash and cash equivalents, and investment securities. At times, the Company has cash, cash equivalents, and investment securities at financial institutions exceeding the Federal Depository Insurance Company (“FDIC”) and the Securities Investor Protection Corporation (“SIPC”) insured limit on domestic currency and the Netherlands’ FDIC counterpart for foreign currency. The Company only deals with reputable financial institutions and has not experienced any losses in such accounts. </font></div></div>
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;padding-top:0px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#000000;">The preparation of these consolidated financial statements in accordance with GAAP requires management to make estimates and judgments that affect the reported amount of assets and liabilities and related disclosure of contingent assets and liabilities at the date of our consolidated financial statements and the reported amounts of revenues and expenses during the applicable period. Actual results may differ from these estimates under different assumptions or conditions. Such differences could be material to the consolidated financial statements.</font></div></div>

Files In Submission

Name	View Source	Status
0001213809-19-000061-index-headers.html	Edgar Link	pending
0001213809-19-000061-index.html	Edgar Link	pending
0001213809-19-000061.txt	Edgar Link	pending
0001213809-19-000061-xbrl.zip	Edgar Link	pending
dyadiclogoa05.jpg	Edgar Link	pending
dyai-20190630.xml	Edgar Link	completed
dyai-20190630.xsd	Edgar Link	pending
dyai-20190630_cal.xml	Edgar Link	unprocessable
dyai-20190630_def.xml	Edgar Link	unprocessable
dyai-20190630_lab.xml	Edgar Link	unprocessable
dyai-20190630_pre.xml	Edgar Link	unprocessable
exhibit311certifications-m.htm	Edgar Link	pending
exhibit312certifications-p.htm	Edgar Link	pending
exhibit321sectopm1350certi.htm	Edgar Link	pending
exhibit322sectopm1350certi.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
q2201910-qdyai.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$DYAI
Dyadic International Inc Stock $dyai

2019 Q3 Form 10-Q Financial Statement

#000121380919000061 Filed on August 13, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DYAI Dyadic International Inc Stock $dyai

2019 Q3 Form 10-Q Financial Statement

#000121380919000061 Filed on August 13, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DYAI
Dyadic International Inc Stock $dyai